Digestery
Everyday supplements › Berberine, Weight and Blood Sugar › Studies

Randomized trial · measured other health measures

A 12-week berberine trial in 70 adults with fatty liver found no clear difference

Koperska and colleagues · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2024

Original title: Does berberine impact anthropometric, hepatic, and metabolic parameters in patients with metabolic dysfunction-associated fatty liver disease? Randomized, double-blind placebo-controlled trial.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

No difference

Berberine lowered liver enzyme ALT (p=0.0105) and total cholesterol (p=0.0009) more than placebo. Trunk fat fell in both groups. No differences between groups in other lipid and glucose measures.

The study at a glance

Type of study
Randomized trial
Who or what was studied
70 people · Adults with fatty liver disease
What was tested
Berberine 1500 mg a day for 12 weeks, vs placebo
What it measured
Several kinds of outcomes
Daily amount
1500 mg a day
How long
12 weeks
Who has a stake
No disclosure in PubMed
No disclosure in PubMed.
Journal
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2024
Source
PubMed record 39042390. This page is based on the abstract only.

How much this study counts

  • ✓Randomized: people were put into groups by chance, so the groups start out alike.
  • ✓Compared with a placebo, a dummy treatment.
  • •Medium size: 70 people.
  • •Lasted 12 weeks.
  • •Measured several kinds of outcomes.
  • •The PubMed record has no conflict-of-interest statement.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

Each dot is one on-topic paper on this question. Steps near the top answer the question more directly.

↑ Stronger evidence

  1. Trials in people: weight and blood sugar

    7

    7 benefit

  2. Trials in people: other measures

    7

    5 benefit, 1 mixed, 1 no difference

    ↑ This study is the ringed dot

  3. Trials in people: lab tests or safety

    2

    1 benefit, 1 no difference

  4. Population studies

    2

    2 benefit

  5. Blood levels and genes

    0

    None among the papers we read.

  6. Animals

    1

    1 benefit

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does berberine help with weight loss and blood sugar?”

Lowers blood sugar in diabetes; weight unclear.

Confidence: low. Based on 28 on-topic papers.

Read the full answer

Of the other 6 papers on the same step: 5 benefit, 1 mixed. This one found no difference. It differs from most of them.

Other papers on the same step

See all 28 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The reviewer corrected 1 field after reading the abstract. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.